Arrowhead Research Corp. Company Profile (NASDAQ:ARWR)

About Arrowhead Research Corp.

Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, is a biopharmaceutical company. The Company is engaged in developing RiboNucleic Acid interference (RNAi) therapeutics. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA. ARC-520 is designed to treat chronic hepatitis B virus (HBV) infection. ARC-AAT is an unlocked nucleobase analog containing RNAi-based therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency (AATD). Its Dynamic Polyconjugate platform is an RNAi delivery system that promotes high levels of target gene knockdown. ARC-F12 is an RNAi-based therapeutic designed to reduce the production of factor 12 for providing a prophylactic treatment for hereditary angioedema and thromboembolic diseases. ARC-LPA is an RNAi-based therapeutic designed to reduce production of apolipoprotein A. ARC-HIF2 is an RNAi-based therapeutic designed to reduce the production of hypoxia-inducible factor 2a.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Exchange: NASDAQ
• Symbol: ARWR
• CUSIP:

Key Metrics:

• Previous Close: $7.13
• 50 Day Moving Average: $6.99
• 200 Day Moving Average: $5.93
• 52-Week Range: $3.07 - $8.22
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -5.14
• P/E Growth: -0.73
• Market Cap: $427.68M
• Outstanding Shares: 60,750,000
• Beta: 2.55

Profitability:

• Net Margins: -48,980.81%
• Return on Equity: -100.50%
• Return on Assets: -79.52%

Debt:

• Debt-to-Equity Ratio: 0.05%
• Current Ratio: 3.34%
• Quick Ratio: 3.34%

Additional Links:

• Visit Arrowhead Research Corp.'s Official Website
• View ARWR on Google Finance
• View ARWR on Yahoo Finance
• View ARWR's Company Profile on Reuters
• Search for Arrowhead Research Corp. on Google

Companies Related to Arrowhead Research Corp.:

• Vascular Solutions (NASDAQ:VASC)
• PharMerica Corp. (NYSE:PMC)
• Foundation Medicine (NASDAQ:FMI)
• Momenta Pharmaceuticals (NASDAQ:MNTA)
• AMAG Pharmaceuticals (NASDAQ:AMAG)
• Pacific Biosciences of California (NASDAQ:PACB)
• Teladoc (NYSE:TDOC)
• Meridian Bioscience (NASDAQ:VIVO)
• Global Blood Therapeutics (NASDAQ:GBT)
• Retrophin (NASDAQ:RTRX)

Earnings

Earnings History for Arrowhead Research Corp. (NASDAQ:ARWR)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
12/12/2016
8/9/2016	Q316	($0.37)	($0.32)	$0.05 million	$39.58 million	View	N/A
5/10/2016	Q216	($0.37)	($0.35)			View	Listen
2/9/2016	Q1	($0.41)	($0.32)			View	N/A
12/14/2015	Q415	($0.39)	($0.42)			View	Listen
8/4/2015	Q315	($0.38)	($0.27)			View	N/A
5/11/2015	Q214	($0.35)	($0.33)	$110.00 million	$43.75 million	View	Listen
2/9/2015	Q114	($0.34)	($0.41)			View	N/A
11/25/2014	Q413	($0.24)	($0.33)	$40.00 million		View	N/A
8/12/2014	Q313	($0.22)	($0.22)			View	N/A
5/6/2014		($0.20)	($0.31)			View	N/A
2/4/2014	Q4	($0.18)	($0.33)			View	N/A
12/18/2013	Q4	($0.23)	($0.43)			View	Listen
5/9/2013	Q2 2013		($0.41)			View	N/A
2/13/2013	Q1 2013		($0.33)			View	N/A
12/20/2012	Q4 2012		($0.43)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Arrowhead Research Corp. (NASDAQ:ARWR)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	3	($0.44)	($0.35)	($0.39)
Q2 2016	3	($0.42)	($0.37)	($0.39)
Q3 2016	2	($0.40)	($0.38)	($0.39)
Q4 2016	2	($0.34)	($0.31)	($0.33)
Q1 2017	1	($0.33)	($0.33)	($0.33)
Q2 2017	1	($0.36)	($0.36)	($0.36)
Q3 2017	1	($0.33)	($0.33)	($0.33)
Q4 2017	1	($0.36)	($0.36)	($0.36)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Arrowhead Research Corp. (NASDAQ:ARWR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Arrowhead Research Corp. (NASDAQ:ARWR)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
8/23/2016	Kenneth Allen Myszkowski	CFO	Sell	6,900	$8.00	$55,200.00
8/22/2016	Kenneth Allen Myszkowski	CFO	Sell	13,100	$8.00	$104,800.00
12/30/2015	Kenneth Allen Myszkowski	CFO	Sell	23,347	$6.13	$143,117.11
10/28/2015	Mauro Ferrari	Director	Buy	400	$7.62	$3,048.00
10/9/2015	Mauro Ferrari	Director	Buy	1,900	$6.19	$11,761.00
1/5/2015	David L Lewis	Insider	Sell	15,000	$8.01	$120,150.00
10/15/2014	Christopher Richard Anzalone	CEO	Buy	16,000	$6.32	$101,120.00
10/1/2014	Charles Mckenney	Director	Sell	2,500	$14.70	$36,750.00
9/30/2014	David L Lewis	Insider	Sell	15,000	$15.02	$225,300.00
9/26/2014	Douglas B Given	Director	Sell	2,000	$15.24	$30,480.00
6/9/2014	Charles Mckenney	Director	Sell	22,000	$14.32	$315,040.00
2/12/2014	Kenneth Allen Myszkowski	CFO	Sell	16,000	$18.77	$300,320.00
2/7/2014	Edward W Frykman	Director	Sell	3,148	$15.98	$50,305.04

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Arrowhead Research Corp. (NASDAQ:ARWR)

Date	Headline
	ARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of (NASDAQ:ARWR) biz.yahoo.com - September 29 at 8:23 AM
	Stock Perspective: Arrowhead Research Corporation (NASDAQ:ARWR) Company Earnings Watch - Frisco Fastball (NASDAQ:ARWR) friscofastball.com - September 14 at 8:49 PM
	What are Analysts Expecting for Arrowhead Research Corporation ... - Frisco Fastball (NASDAQ:ARWR) friscofastball.com - September 13 at 3:35 PM
	Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) earnings reaction history - The Independent Republic (NASDAQ:ARWR) theindependentrepublic.com - September 12 at 3:34 PM
	Intraday Active Biotech Stocks News: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), Peregrine Pharmaceuticals ... - The Voice Registrar (NASDAQ:ARWR) voiceregistrar.com - September 12 at 3:34 PM
	Will Arrowhead Research Corporation (NASDAQ:ARWR) Surprise Analysts? - Investor Newswire (NASDAQ:ARWR) www.investornewswire.com - September 11 at 8:21 AM
	Placing Arrowhead Research Corporation (NASDAQ:ARWR) Shares Under the Microscope - Post News (NASDAQ:ARWR) www.kentuckypostnews.com - September 9 at 8:23 AM
	Chardan Capital Reiterates Buy at Arrowhead Research Corp. (NASDAQ: ARWR) - BNB Daily (blog) (NASDAQ:ARWR) www.baseball-news-blog.com - September 8 at 10:02 AM
	Arrowhead Pharmaceuticals Initiates Phase 2 Study of ARC-AAT (NASDAQ:ARWR) finance.yahoo.com - September 6 at 8:23 AM
	7:31 am Arrowhead initiates a Phase 2 clinical study of ARC-AAT, an investigational RNAi-based medicine for the treatment of liver disease associated with alpha-1 antitrypsin deficiency (NASDAQ:ARWR) finance.yahoo.com - September 6 at 8:22 AM
	Arrowhead Pharmaceuticals to Present at Upcoming September Conferences (NASDAQ:ARWR) au.finance.yahoo.com - September 1 at 12:02 PM
	Kenneth Allen Myszkowski Sells 6900 Shares of Arrowhead Research Corp. (ARWR) Stock (NASDAQ:ARWR) larampadinapoli.com - August 25 at 8:59 PM
	Arrowhead (ARWR) Exited Third Quarter with a Strong Balance Sheet (NASDAQ:ARWR) finance.yahoo.com - August 23 at 3:36 PM
	Crowd Perspectives & Analyst Views on Arrowhead Research Corporation (NASDAQ:ARWR)? - Post News (NASDAQ:ARWR) www.kentuckypostnews.com - August 21 at 3:33 PM
	ETF’s with exposure to Arrowhead Pharmaceuticals, Inc. : August 19, 2016 (NASDAQ:ARWR) www.capitalcube.com - August 19 at 4:14 PM
	ARROWHEAD PHARMACEUTICALS, INC. Financials (NASDAQ:ARWR) finance.yahoo.com - August 18 at 3:43 PM
	What Caused Arrowhead Pharmaceuticals to Skyrocket 12.5% Today (NASDAQ:ARWR) www.fool.com - August 18 at 3:43 PM
	Coverage initiated on Arrowhead by Cantor Fitzgerald (NASDAQ:ARWR) finance.yahoo.com - August 18 at 11:59 AM
	Arrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARWR-US : August 15, 2016 (NASDAQ:ARWR) www.capitalcube.com - August 15 at 10:49 AM
	Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q3, 2016 By the Numbers : August 12, 2016 (NASDAQ:ARWR) www.capitalcube.com - August 12 at 3:47 PM
	Arrowhead Pharmaceuticals Closes $45 Million Private Offering (NASDAQ:ARWR) www.publicnow.com - August 12 at 12:12 PM
	Biotech Company Targeting a $12 Billion Market (NASDAQ:ARWR) www.ssuchronicle.com - August 11 at 12:49 PM
	ARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial S (NASDAQ:ARWR) biz.yahoo.com - August 10 at 10:02 PM
	Arrowhead Pharmaceuticals plans to raise $45 million (NASDAQ:ARWR) host.madison.com - August 10 at 9:39 AM
	Arrowhead Research reports 3Q loss (NASDAQ:ARWR) www.cnbc.com - August 10 at 9:39 AM
	Edited Transcript of ARWR earnings conference call or presentation 9-Aug-16 8:30pm GMT (NASDAQ:ARWR) finance.yahoo.com - August 10 at 9:39 AM
	Arrowhead Reports Fiscal 2016 Third Quarter Results (NASDAQ:ARWR) finance.yahoo.com - August 9 at 4:40 PM
	ARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen (NASDAQ:ARWR) biz.yahoo.com - August 9 at 4:40 PM
	Arrowhead Pharmaceuticals Prices $45 Million Private Offering (NASDAQ:ARWR) www.publicnow.com - August 9 at 12:25 PM
	ETF’s with exposure to Arrowhead Pharmaceuticals, Inc. : August 8, 2016 (NASDAQ:ARWR) www.capitalcube.com - August 8 at 3:38 PM
	Arrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARWR-US : August 3, 2016 (NASDAQ:ARWR) www.capitalcube.com - August 3 at 12:12 PM
	Arrowhead Research Corporation: Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Third Quarter Results (NASDAQ:ARWR) www.twst.com - August 2 at 9:16 PM
	Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Third Quarter Results (NASDAQ:ARWR) www.publicnow.com - August 2 at 8:22 AM
	Arrowhead Research Corporation (NASDAQ:ARWR) Updated Price Targets - FTSE News (NASDAQ:ARWR) www.ftsenews.co.uk - July 25 at 8:24 AM
	Earnings Focus and Crowd Sourced Sentiment Review for Arrowhead Research Corporation (NASDAQ:ARWR) - TGP (NASDAQ:ARWR) telanaganapress.com - July 22 at 11:47 AM
	Arrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARWR-US : July 22, 2016 (NASDAQ:ARWR) www.capitalcube.com - July 22 at 8:20 AM
	Equity Roundup: Stock Performance Focus on Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph (NASDAQ:ARWR) presstelegraph.com - July 19 at 3:35 PM
	Crowd Rating and Earnings Recap for Arrowhead Research Corporation (NASDAQ:ARWR) - Telanagana Press (NASDAQ:ARWR) telanaganapress.com - July 16 at 3:34 PM
	Arrowhead Research Corporation (NASDAQ:ARWR) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:ARWR) telanaganapress.com - July 14 at 12:29 PM
	Company Stock Focus for Arrowhead Research Corporation (NASDAQ:ARWR): Which Way Will Shares Head? - Press Telegraph (NASDAQ:ARWR) presstelegraph.com - July 12 at 6:58 AM
	Trading Performance and Target Watch for Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph (NASDAQ:ARWR) presstelegraph.com - July 12 at 6:58 AM
	Arrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARWR-US : July 11, 2016 (NASDAQ:ARWR) www.capitalcube.com - July 11 at 8:40 AM
	Sentiment Report: Arrowhead Research Corp (NASDAQ:ARWR) - Press Telegraph (NASDAQ:ARWR) presstelegraph.com - July 7 at 3:37 PM
	Arrowhead Research Corporation (NASDAQ:ARWR) Stock Update: Check on Ratings and Target Price - Telanagana Press (NASDAQ:ARWR) telanaganapress.com - July 7 at 11:31 AM
	Stock Rating Watch and Earnings Insight for Arrowhead Research Corporation (NASDAQ:ARWR) - Press Telegraph (NASDAQ:ARWR) presstelegraph.com - July 6 at 8:24 AM
	Arrowhead Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:ARWR) www.publicnow.com - July 6 at 8:01 AM
	Arrowhead Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:ARWR) finance.yahoo.com - July 6 at 7:30 AM
	Can Arrowhead Research Corporation (NASDAQ:ARWR) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:ARWR) www.engelwooddaily.com - July 5 at 3:34 PM
	Can Arrowhead Research Corporation (NASDAQ:ARWR) Keep Up with Analyst Expectations? - Investor Newswire (NASDAQ:ARWR) www.investornewswire.com - July 2 at 3:37 PM
	ETF’s with exposure to Arrowhead Pharmaceuticals, Inc. : July 1, 2016 (NASDAQ:ARWR) www.capitalcube.com - July 1 at 5:54 PM

Social

Arrowhead Research Corp. (NASDAQ:ARWR) Chart for Thursday, September, 29, 2016